137 related articles for article (PubMed ID: 38019252)
21. Role of
Barooah P; Saikia S; Bharadwaj R; Sarmah P; Bhattacharyya M; Goswami B; Medhi S
Genet Test Mol Biomarkers; 2019 May; 23(5):325-331. PubMed ID: 30942619
[No Abstract] [Full Text] [Related]
22. Genetic variations of the NPC1L1 gene associated with hepatitis C virus (HCV) infection and biochemical characteristics of HCV patients in China.
Zhang AM; Zhang CL; Song Y; Zhao P; Feng Y; Wang B; Li Z; Liu L; Xia X
Int J Infect Dis; 2016 Dec; 53():6-11. PubMed ID: 27769799
[TBL] [Abstract][Full Text] [Related]
23. Association between a functional polymorphism in Toll-like receptor 3 and chronic hepatitis C in liver transplant recipients.
Lee SO; Brown RA; Razonable RR
Transpl Infect Dis; 2013 Apr; 15(2):111-9. PubMed ID: 23240626
[TBL] [Abstract][Full Text] [Related]
24. The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patients.
Nischalke HD; Berger C; Luda C; Müller T; Berg T; Coenen M; Krämer B; Körner C; Trebicka J; Grünhage F; Lammert F; Nattermann J; Sauerbruch T; Spengler U
J Hepatol; 2012 Apr; 56(4):758-64. PubMed ID: 22173151
[TBL] [Abstract][Full Text] [Related]
25. Promoter region polymorphism & expression profile of toll like receptor-3 (TLR-3) gene in chronic hepatitis C virus (HCV) patients from India.
Medhi S; Deka M; Deka P; Swargiary SS; Hazam RK; Sharma MP; Gumma PK; Asim M; Kar P
Indian J Med Res; 2011 Aug; 134(2):200-7. PubMed ID: 21911973
[TBL] [Abstract][Full Text] [Related]
26. Association of Genetic Polymorphisms With Hepatitis C Virus-related Liver Cirrhosis in Japan.
Kamimura S; Tamura A; Ishii T; Kanda T; Moriyama M
In Vivo; 2020; 34(6):3309-3313. PubMed ID: 33144438
[TBL] [Abstract][Full Text] [Related]
27. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
28. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
[TBL] [Abstract][Full Text] [Related]
29. The Impact of Interferon-γ (IFN-γ) and IFN-γ-Inducible Protein 10 (IP-10) Genes' Polymorphism on Risk of Hepatitis C Virus-Related Liver Cirrhosis.
Talaat RM; Elsharnoby S; Abdelkhalek MS; El-Shenawy SZ; Elmasry S
Immunol Invest; 2022 Apr; 51(3):688-704. PubMed ID: 33445993
[TBL] [Abstract][Full Text] [Related]
30. Impact of IL-27p28 (rs153109) and TNF-α (rs1800629) Genetic Polymorphisms on the Progression of HCV Infection in Egyptian Patients.
Tharwat E; Gad GFM; Nazmy MH; Mohamed HI; Hamza N; Wahid A; Ibrahim ARN
Immunol Invest; 2019 Apr; 48(3):255-267. PubMed ID: 30204505
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor-alpha -308G/A polymorphism and risk of hepatocellular carcinoma in hepatitis C virus-infected patients.
Talaat RM; Esmail AA; Elwakil R; Gurgis AA; Nasr MI
Chin J Cancer; 2012 Jan; 31(1):29-35. PubMed ID: 22200181
[TBL] [Abstract][Full Text] [Related]
33. TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients.
Jiménez-Sousa MA; Rallón N; Berenguer J; Pineda-Tenor D; López JC; Soriano V; Guzmán-Fulgencio M; Cosín J; Retana D; García-Álvarez M; Miralles P; Benito JM; Resino S
J Clin Virol; 2015 Apr; 65():62-7. PubMed ID: 25766991
[TBL] [Abstract][Full Text] [Related]
34. Disheveled EGL-10 and pleckstrin domain-containing 5 rs1012068 T/G gene polymorphism among Egyptian chronic HCV-infected patients: disease progression and related complications.
Farhan HM; Abougabal K; Gaber HF; Attia D
Egypt J Immunol; 2022 Jul; 29(3):36-43. PubMed ID: 35758967
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study.
Simonetti RG; Cammà C; Fiorello F; Cottone M; Rapicetta M; Marino L; Fiorentino G; Craxì A; Ciccaglione A; Giuseppetti R
Ann Intern Med; 1992 Jan; 116(2):97-102. PubMed ID: 1309286
[TBL] [Abstract][Full Text] [Related]
36. Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients.
Jadid FZ; Chihab H; Alj HS; Elfihry R; Zaidane I; Tazi S; Badre W; Marchio A; El Filali KM; Tahiri M; Saile R; Pineau P; Ezzikouri S; Benjelloun S
Infect Genet Evol; 2018 Dec; 66():1-8. PubMed ID: 30172885
[TBL] [Abstract][Full Text] [Related]
37. Treatment of chronic hepatitis C in Asia: when East meets West.
Yu ML; Chuang WL
J Gastroenterol Hepatol; 2009 Mar; 24(3):336-45. PubMed ID: 19335784
[TBL] [Abstract][Full Text] [Related]
38. Impaired toll-like receptor 3-mediated immune responses from macrophages of patients chronically infected with hepatitis C virus.
Qian F; Bolen CR; Jing C; Wang X; Zheng W; Zhao H; Fikrig E; Bruce RD; Kleinstein SH; Montgomery RR
Clin Vaccine Immunol; 2013 Feb; 20(2):146-55. PubMed ID: 23220997
[TBL] [Abstract][Full Text] [Related]
39. Association of genetic polymorphism of low-density lipoprotein receptor with chronic viral hepatitis C infection in Han Chinese.
Li H; Liu Z; Han Q; Li Y; Chen J
J Med Virol; 2006 Oct; 78(10):1289-95. PubMed ID: 16927291
[TBL] [Abstract][Full Text] [Related]
40. HCV genotypes and age distribution in patients of Vienna and surrounding areas.
Haushofer AC; Kopty C; Hauer R; Brunner H; Halbmayer WM
J Clin Virol; 2001 Jan; 20(1-2):41-7. PubMed ID: 11163582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
